Preclinical Studies Reveal That LSD1 Inhibition Results in Tumor Growth Arrest in Lung Adenocarcinoma Independently of Driver Mutations

Molecular Oncology- Netherlands

doi 10.1002/1878-0261.12382

Full Text

Abstract

Available in

Categories

Cancer Research

Molecular Medicine

Date

October 13, 2018

Authors

Iris F. Macheleidt

Karolin Kleemann

Peter Nürnberg

Vanessa Rüsseler

Stephan C. Schäfer

Reinhard Büttner

Margarete Odenthal

Publisher

Wiley

Related search

Common Driver Mutations and Smoking History Affect Tumor Mutation Burden in Lung Adenocarcinoma

Journal of Surgical Research

English

Decoding Tumor Mutation Burden and Driver Mutations in Early Stage Lung Adenocarcinoma Using CT‐based Radiomics Signature

Thoracic Cancer

Respiratory Medicine

English

ARID1A Gene Driver Mutations in Lung Adenocarcinomas

Journal of Thoracic Oncology

Respiratory Medicine

German

P2.13-36 Analysis of CDK4/6 Pathway Activity in Lung Adenocarcinoma Patients With Oncogenic Driver Mutations in China

Journal of Thoracic Oncology

Respiratory Medicine

English

Inhibition of Acetyl-CoA Carboxylase Suppresses Fatty Acid Synthesis and Tumor Growth of Non-Small-Cell Lung Cancer in Preclinical Models

Nature Medicine

Molecular Biology

English

P3.13-27 Clinical Outcomes of Patients With Lung Adenocarcinoma Harboring Concomitant Driver Mutations in a Brazilian Cancer Center

Journal of Thoracic Oncology

Respiratory Medicine

English

Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK Among Treatment-Naïve Patients With Advanced Lung Adenocarcinoma

Multidisciplinary

English

Detection of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma Cytological Specimens by Immunocytochemistry

Molecular and Clinical Oncology

Cancer Research

English

Role of G0-G1 Arrest in the Inhibition of Tumor Cell Growth by Interferon.

Proceedings of the National Academy of Sciences of the United States of America

Multidisciplinary

English